Showing results (61-70 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|September 18, 2021
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanismLuca Simula, Ylenia Antonucci, Giorgia Scarpelli, et al.
Molecular Oncology|September 18, 2021
Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathwayAngélica Díaz-Basabe, Claudia Burrello, Georgia Lattanzi, et al.
Molecular Oncology|September 14, 2021
The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressorDanny Legge, Ling Li, Whei Moriarty, et al.
Molecular Oncology|September 5, 2021
STAT3 is required for Smo-dependent signaling and mediates Smo-targeted treatment resistance and tumorigenesis in Shh medulloblastomaLiangping Yuan, Hongying Zhang, Jingbo Liu, et al.
Molecular Oncology|September 2, 2025
Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow-up biomarkers for breast cancerNicholas Rajan, Irina Primac, Emre Etlioglu, et al.
Molecular Oncology|May 25, 2015
CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonistSangjun Lee, Eileen L Heinrich, Lily Li, et al.
Molecular Oncology|May 11, 2015
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferationK V Woan, M Lienlaf, P Perez-Villaroel, et al.
Molecular Oncology|May 27, 2015
Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancerJay Pundavela, Severine Roselli, Sam Faulkner, et al.
Molecular Oncology|June 1, 2015
High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancyIrina Gromova, Pavel Gromov, Naoko Honma, et al.
Molecular Oncology|May 10, 2020
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylationHirofumi Yoshino, Hideki Enokida, Yoichi Osako, et al.
Pageof 258